PLEXIFORM FIBROHISTIOCYTIC TUMOR

Clinical trials for PLEXIFORM FIBROHISTIOCYTIC TUMOR explained in plain language.

Never miss a new study

Get alerted when new PLEXIFORM FIBROHISTIOCYTIC TUMOR trials appear

Sign up with your email to follow new studies for PLEXIFORM FIBROHISTIOCYTIC TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for tough sarcomas: adding a targeted drug to standard treatment

Disease control Ongoing

This study is for patients with newly diagnosed, high-risk soft tissue sarcomas that can be removed by surgery. It tests whether adding a drug called pazopanib to standard pre-surgery treatments (radiation with or without chemotherapy) helps shrink tumors more effectively and imp…

Matched conditions: PLEXIFORM FIBROHISTIOCYTIC TUMOR

Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 25, 2026 14:09 UTC

PLEXIFORM FIBROHISTIOCYTIC TUMOR

Get alerted when new PLEXIFORM FIBROHISTIOCYTIC TUMOR trials appear

New hope for tough sarcomas: adding a targeted drug to standard treatment